The management of anal fistulas is one of the greatest challenges. The need to preserve continence while permanently eradicating the fistula is the ultimate desired goal. Unfortunately, none of the ever-expanding myriads of treatments is a panacea; high rates of failure and of recurrence are consistently experienced. Regenerative or autologous tissue replacement therapies differ from all other options in encouraging tissue growth rather than destroying, ablating, or excising tissue. This program will demonstrate the role of autologous stem cells and gracilis muscle interposition in the treatment of some of the most challenging fistulas.
Clinical Background
Welcome & Introduction – Dr. Steven D. Wexner (USA)
How Regenerative Medicine is Changing the Treatment of Inflammatory Bowel Disease - Dr. Amy Lightner (USA)
The results of stem cells for fecal incontinence - Dr. Lucia Oliveira (Brazil)
Development of stem cells for fistulas - Dr. Damian Garcia (Spain)
Treating incontinence after fistula surgery – Dr. Liliana Bordeianou (USA)
The results of gracilis interposition for complex perineal fistulas - Dr. Sameh Emile (Egypt)
Video gracilis interposition for rectovaginal and rectourethral fistulas - Dr. Zoe Garoufalia (Greece)
Panel discussion & Closing Remarks - All faculty moderated by Dr. Steven D. Wexner (USA)
Technique Description
*Supported by an educational grant from Takeda Pharmaceuticals U.S.A.
Share it with your network and help spread clinical knowledge.
